Mikio Osawa¹, Mutsumi Iijima² (1.Botulinum Toxin Therapy Center, Tokyo Clinic, Japan, 2.Department of Neurology, Tokyo Women's University, Japan)

Masahiro Nakamura¹, Osamu Isono^1,2, Tetsuya Nasu^1,2, Yuji Hinuma^1,2, Noriko Nakamura^1,2 (1.Kyoto Min-iren Asukai Hospital, Japan, 2.kyoto Min-iren Asukai Hospital, Japan)

Ryosuke Igari¹, Hiroyasu Sato¹, Chifumi Iseki¹, Mana Higashihara², Masahiro Sonoo³, Yasuyuki Ohta¹ (1.Division of Neurology and Clinical Neuroscience, Department of Internal Medicine 3rd, Yamagata University School of Medicine, Japan, 2.Department of Neurology, Tokyo Metropolitan Geriatric Hospital, Japan, 3.Department of Neurology, Teikyo University School of Medicine, Japan)

Yuma Sato¹, Takashi Sugiyama¹, Hitoshi Mochizuki⁴, Nobuyuki Ishii³, Yuka Ebihara⁴, Taiga Miyazaki², Kazutaka Shiomi¹ (1.Department of Neurology, Faculty of Medicine, University of Miyazaki Hospital, Japan, 2.Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan, 3.Department of Neurology, Chiyoda Hospital, Japan, 4.Department of Neurology, Ebihara General Hospital, Japan)

Taichiro Ashizaki¹, Masaya Togo¹, Kazuma Koda¹, Masamune Kimura¹, Kohei Morimoto¹, Kento Matoba¹, Norio Chihara¹, Kenji Sekiguchi¹, Yasufumi Kageyama², Riki Matsumoto¹ (1.Division of Neurology, Kobe University Graduate School of Medicine, Japan, 2.Hyogo Prefectural Amagasaki General Medical Center, Japan)